John F. Kokai-Kun, PhD is Vice President of Non-clinical Affairs for Synthetic Biologics, Inc. (Rockville, MD). He received his BS in Biochemistry from Juniata College in Huntingdon, PA and his PhD in Microbiology from the University of Pittsburgh, School of Medicine. He served as a post-doctoral researcher at the Uniformed Services University of the Health Sciences in Bethesda, MD. Dr. Kokai-Kun has 20 years of experience in the drug development industry and has held positions with several biotechnology and pharmaceutical companies where his research and development efforts have focused primarily on anti-bacterial drugs and vaccines. He is also an Adjunct Assistant Professor of Microbiology and Immunology at the Uniformed Services University and retired from the United States Army.

Anti-bacterial drugs and vaccines

Deb Mathews received her doctorate of Pharmacy degree from Florida A&M University and has over 25 years of clinical and pharmaceutical executive experience. She spent her early years in clinical practice as research pharmacist in Oncology with the University of Miami Hospital and Head of Pharmacy Services / Adherence Manager for the HIV/AIDS program with Jackson Memorial Hospital in Miami. She has worked in several leadership positions with the pharmaceutical industry focused on Medical Affairs, scientific insights, publications and data dissemination. She currently serves as Vice-President Medical Affairs for Synthetic Biologics, Inc. She is interested in mechanistic methodologies for personalized medicine in antimicrobial resistance and biomarker identification linked to clinical outcomes

Mechanistic methodologies for personalized medicine in antimicrobial resistance and biomarker identification linked to clinical outcomes.

John J.S. Cadwell received his degree in pharmacology from the University of Miami in 1981. He spent additional time studying at the University of Nottingham and the National Institute of Medical Research at Mill Hill, outside of London. He served in various capacities in the biomedical research fields until 2000 when he was founder of FiberCell Systems Inc. a company specializing in the research and supply of hollow fiber bioreactors. He has over 10 publications in the field and three patents relating to hollow fiber systems and is considered a world expert in the field.

Cell culture technology, stem cells, numismatics, oenophilia, cerevisaphilia, rock art posters, gratefuldeadophilia.

Byungse Suh has completed his BS in pharmacy from Chungang University, Seoul, Korea; PhD at the age of 28 from University of Kansas; postdoctoral studies from University of Iowa; and MD from University of Miami. He has completed the residency and fellowship from University of Wisconsin Hospital. He is Professor of Medicine and published more than 110 papers.

Pharmacokinetics of antimicrobial agents Drug protein binding in disease states In vitro determination of drug phototoxicity Clinical trial studies of antimicrobial agents

Tadashi Shimamoto has completed his PhD at the age of 28 years from Okayama University, Japan and postdoctoral studies from University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School. He is a professor and a vice dean of Graduate School of Biosphere Science, Hiroshima University. He has published more than 60 papers in reputed journals and has been serving as an editorial board member of Microbiology and Immunology.

Microorganisms that cause food poisoning, such as E. coli O157, Salmonella, Vibrio parahaemolyticus, Campylobacter and norovirus.

Bing Xie is a full Professor in School of Ecology and Environmental Science, East China Normal University. He got his PhD of Environment Engineering and Master of Environment Microbiology in China. His work is multi-disciplinary, ranging from studies on solid waste/wastewater treatment and bioremediation, and microbial ecology. Current and recent projects include control strategies of antibiotic resistance genes (ARGs) during waste treatment, and the ecological risk assessment of ARGs in urban water; Bioremediation subjected to nutrient removal, and studying microbial ecology of complex communities using innovative molecular techniques.

Pollution control and Microbiology technology

Prof Samir Kumar-Singh is a certified medical doctor with a doctorate in Pathology and a Master degree in Laboratory Animals. He is a full-time research professor of Molecular Pathology at the Faculty of Medicine, University of Antwerp, Belgium and is affiliated to the Vaccine and Infectious Disease Institute, Belgium. He has published a well-cited body of work on molecular pathology of cancer and neurodegeneration involving patient studies and mouse modelling. Professor Kumar-Singh serves on several review and editorial boards and international consortia. Since 2012, his group is engaged in studying the pathomechanism of hospital acquired pneumonia especially ventilator-associated pneumonia (VAP) and has developed several authentic rat and mouse VAP as well as acute and chronic pneumonia models to study disease pathogenesis and for biomarker discovery as well as high-throughput in vitro screens for new antimicrobial targets.

Biomarker discovery, New antimicrobial targets

Anna Malm has completed her PhD in 1989 from Medical University in Lublin, Poland. She is the head of Department of Pharmaceutical Microbiology in Medical University in Lublin. She works at full professor position. She is a specialist in medical microbiology. She has published more than 200 papers mainly in reputed journals in the field of medical microbiology, including studies on antibacterial/antifungal activity in vitro of the compounds of plant or synthetic origin.

Pharmaceutical Microbiology

Professor, MD, PhD, Lia Monica Junie, from the Microbiology Department of “Iuliu Hatieganu” University of Medicine and Pharmacy, Cluj-Napoca, Romania. She is head of the Department, coordinating also, the activities of both Laboratory Medicine specialty resident doctors and PhD doctor’s thesis in the medicine field. She unfolds a fruitful National and International scientific activity as an experienced microbiologist, having an impressive CV. She is Member in the Board of Scientific Societies, Reviewer in many peer-reviewed journals, Expert of the Ministry of Education and Research and Evaluator. She coordinated research projects, published books and more than 200 scientific articles in prestigious Journals. She organized and attended numerous national, international congresses, as president, member in the Organizing Committees, Invited speaker, Keynote speaker or Chairperson.

Infectious Diseases and Microbiology

Professor Surbhi Malhotra-Kumar is a clinical and molecular microbiologist, actively involved in the development of high-throughput and POC diagnostic assays for hospital and community pathogens. Using state-of-the-art molecular techniques, she is studying the impact of antibiotic use at the individual level and the role of virulence factors in biofilm formation as well as utilising metagenomics to study bacterial pathogenetic mechanisms and antibiotic resistance.

Antibiotic resistance